Treatment-Related Adverse Events in Patients With Solid Tumours Receiving Neoadjuvant and Adjuvant Immune Checkpoint Blockade
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials
Lancet Oncol 2023 Nov 24;[EPub Ahead of Print], Y Fujiwara, N Horita, E Adib, S Zhou, AH Nassar, ZUA Asad, A Cortellini, AR NaqashFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.